Phase II, Open Label Study of Ispinesib in Subjects With Advanced or Metastatic Breast Cancer
Phase of Trial: Phase II
Latest Information Update: 09 Oct 2008
At a glance
- Drugs Ispinesib (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 09 Oct 2008 Checked against ClinicalTrials.gov record - last updated 9 Oct 2008.
- 05 Dec 2006 Status change
- 19 Aug 2005 New trial record.